We discovered the TFs that are sequentially and significantly upregulated as carcinoma cells progress through the EMT process and demonstrated that ZEB1 and ZEB2 play pivotal roles in initiating and sustaining the EMT phenotype. The gene discussed is ZEB2; the disease is carcinoma.